NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/06/2025
Back to search
Official data from USPTO
HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/07/2025
Classification
Registered
Trademark type
Combined
Nice classes
35, 41
Filing date
05/11/2017
Registration date
07/23/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2025
Last transaction
06/07/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2016-10-00
First use in commerce
2016-10-00
Drawing code
3
Owner type
99
Owner location
Milwaukee, WI
Examiner
HUDSON, TAMARA
Current location
Historical data usage
Mark description
The mark consists of a swirl design above the word "HOPA", over the words "HEMATOLOGY/ONCOLOGY", over the words "PHARMACY ASSOCIATION".
Holders and representatives
Holders
Hematology Oncology Pharmacy Association, Inc.
Hematology Oncology Pharmacy Association, Inc.
Representatives
Melissa A. Vallone BARNES & THORNBURG LLP
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Association servicespromoting and supporting pharmacy practitioners in the area of hematology/oncology to achieve advances in the optimization of care of individuals affected by cancer
Class 41
Educational servicesproviding educational conferences and webinarsin the field of hematology/oncology pharmacy
Publications
History of USPTO decisions and trademark events.
33 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/05/2025
E815
TEAS SECTION 8 & 15 RECEIVED
02/12/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2018
GNRT
NON-FINAL ACTION E-MAILED
09/26/2018
CNRT
NON-FINAL ACTION WRITTEN
09/26/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2018
GNRT
NON-FINAL ACTION E-MAILED
02/02/2018
CNRT
NON-FINAL ACTION WRITTEN
02/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2018
DOCK
ASSIGNED TO EXAMINER
01/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2017
GNRT
NON-FINAL ACTION E-MAILED
08/11/2017
CNRT
NON-FINAL ACTION WRITTEN
08/11/2017
DOCK
ASSIGNED TO EXAMINER
08/10/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/17/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/16/2017
NWAP
NEW APPLICATION ENTERED
05/15/2017
Continuous trademark protection
Get notified about every new filing that threatens HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.